alexa Overcoming Biological Barriers In Severe Lung Diseases Through Tailored Inhalable Nanoparticles | 70685
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology

Francesca Ungaro
University of Napoli Federico II, Italy
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439-C1-049
Abstract
Lung delivery represents a fascinating option to limit ubiquitous distribution of systemically, and often chronically, administered drugs used to treat severe pulmonary diseases. Nonetheless, clinical outcomes of inhaled therapies strongly depend on drug ability to deposit along the airways and to overcome barriers imposed by the lungs. In this context, the general aim of our studies is the development of inhalable nanomedicines able to deliver the intact drug in the lungs and to shield its interactions with lung lining fluids while enhancing drug availability at the cell target. This objective has been pursued through the design and production of differently engineered nanoparticulate systems with increasing levels of complexity, driven by technological and biological design rules. Some examples, such as drug nanocrystals, micelles and biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles, will be discussed highlighting how the most appropriate formulation approach can be selected only taking into account the distinct physico-chemical profile of the drug under investigation (e.g., molecular weight, solubility, stability) and the peculiarities of the lung pathology (e.g., cystic fibrosis, lung cancer). Surface engineering of nanocarriers with either polymers or phospholipids turns out as crucial to face the current challenge of overcoming lung barriers, especially mucus. Last but not least, in vitro/in vivo studies represent a critical step to select the best formulation to candidate for further development.
Biography

Francesca Ungaro is Associate Professor of Pharmaceutical Technology at the Dept. of Pharmacy of University of Napoli Federico II. Since her PhD, she has been studying innovative delivery systems for small and biotech drugs, with particular regard to micro- and nano-particles. In the last 10 years, special attention has been focused on engineered carriers for inhalation. In particular, she has been coordinating several national and international projects (1 ongoing) aimed to the development of inhalable formulations for cystic fibrosis treatment. She is author of 63 scientific articles in highly-ranked journals, 1 patent, 4 book chapters, 1 editorial and more than 100 presentations at symposia (h-index =22, total citations >1500).

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version